Therapy with a Combination of Low Doses of Interleukin 12 and Chloroquine Completely Cures Blood-Stage Malaria, Prevents Severe Anemia, and Induces Immunity to Reinfection
The immunoregulatory cytokine interleukin 12 (IL-12) induces host resistance against experimental malaria. In this study, we tested the feasibility of using IL-12 in combination with chloroquine (CQ) to rescue susceptible A/J mice from lethal blood-stage Plasmodium chabaudi AS infection. Combined tr...
Spremljeno u:
| Izdano u: | Infect Immun |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1999
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC96349/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9916053/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.67.2.513-519.1999 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
